In vivo corneal epithelial permeability following treatment with prostaglandin analoges with or without benzalkonium chloride

Journal of Ocular Pharmacology and Therapeutics

Volumn 23, Issue 5, 2007, Pages 445-451

  McCarey, Bernard ^a   Edelhauser, Henry ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZALKONIUM CHLORIDE; CARBOXYFLUORESCEIN; LATANOPROST; PROSTAGLANDIN DERIVATIVE; TRAVOPROST;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CORNEA EPITHELIUM; DRUG EFFECT; IN VIVO STUDY; INTRAOCULAR PRESSURE; NONHUMAN; TRANSMISSION ELECTRON MICROSCOPY;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIHYPERTENSIVE AGENTS; BENZALKONIUM COMPOUNDS; CLOPROSTENOL; EPITHELIAL CELLS; EPITHELIUM, CORNEAL; FLUORESCEINS; FLUORESCENT DYES; OPHTHALMIC SOLUTIONS; PERMEABILITY; PRESERVATIVES, PHARMACEUTICAL; PROSTAGLANDINS F, SYNTHETIC; RABBITS; TIGHT JUNCTIONS;

EID: 36749021198     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2007.0024     Document Type: Article

References (24)

1. Weinreb, R.N., and Khaw P.T. Primary open-angle glaucoma. Lancet 363:1711-1720, 2004.
2. Congdon, N., O'Colmain, B., Klaver, C.C., et al. Causes and prevalence of visual impairment among adults in the United States. Arch. Ophthalmol. 122:477-485, 2004.
3. Friedman, D.S., Wolfs, R.C., O'Colmain, B.J, et al. Prevalence of open-angle glaucoma among adults in the United States. Arch. Ophthalmol. 122:532-538, 2004.
4. Quigley, H.A., and Broman, A.T. The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol. 90:262-267, 2006.
5. Guenoun, J.M., Baudouin, C., Rat, P., et al. In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells. Invest. Ophthalmol. Vis. Sci. 46:2444-2450, 2005.
6. Pisella, P.J., Debbasch, C., Hamard, P., et al. Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: An ex vivo and in vitro study. Invest. Ophthalmol. Vis. Sci. 45:1360-1368, 2004.
7. Kovoor, T.A., Kim, A.S., McCulley, J.P., et al. Evaluation of the corneal effects of topical ophthalmic fluoroquinolones using in vivo confocal microscopy. Eye Cont. Lens 30:90-94, 2004.
8. Sherwood, M.B., Grierson, I., Millar, L., et al. Long-term morphologic effects of antiglaucoma drugs on the conjunctiva and Tenon's capsule in glaucomatous patients. Ophthalmology 96:327-335, 1989.
9. Broadway, D., Grierson, I., and Hitchings, R. Adverse effects of topical antiglaucomatous medications on the conjunctiva. Br. J. Ophthalmol. 77:590-596, 1993.
10. Ishibashi, T., Yokoi, N., and Kinoshita, S. Comparison of the short-term effects on the human corneal surface of topical timolol maleate with and without benzalkonium chloride. J. Glaucoma 12:486-490, 2003.
11. De Saint Jean, M., Debbasch, C., Brignole, F., et al. Toxicity of preserved and unpreserved antiglaucoma topical drugs in an in vitro model of conjunctival cells. Curr. Eye Res. 20:85-94, 2000.
12. Yalvac, I.S., Gedikoglu, G., Karagoz, Y., et al. Effects of antiglaucoma drugs on ocular surface. Acta. Ophthalmol. (Scand). 73:246-248, 1995.
13. Malvitte L., Montange T., Vejux A., et al. Measurement of inflammatory cytokines by multicytokine assay in tears of patients with glaucoma topically treated with chronic drugs. Br. J. Ophthalmol. 91:29-32, 2007.
14. Kim, K.S., Lee, J.H., and Edelhauser, H.F. Corneal epithelial permeability after excimer laser photorefractive keratectomy. J. Cataract Refract. Surg. 22:44-50, 1996.
15. Champeau, E.J., and Edelhauser, H.F. Effect of ophthalmic preservatives on the ocular surface: Conjunctival and corneal uptake and distribution of benzalkonium chloride and chlorhexidine digluconate. J. Cutaneous. Toxicol. 5:292-302, 1984.
16. McCarey, B.E., and Reaves, T. Noninvasive measurement of corneal epithelial permeability. Curr. Eye Res. 14:505-510, 1995.
17. Luft, J.H. Ruthenium red and violet. I. Chemistry, purification, methods of use for electron microscopy, and mechanism of action. Anat. Rec. 171:347-368, 1971.
18. Baudouin, C., Pisella, P.J., Fillacier, K., et al. Ocular surface inflammatory changes induced by topical antiglaucoma drugs: Human and animal studies. Ophthalmology 106:556-563, 1999.
19. Kuppens, E.V., de Jong, C.A., Stolwijk, T.R., et al. Effect of timolol with and without preservative on the basal tear turnover in glaucoma. Br. J. Ophthalmol. 79:339-342, 1995.
20. Fisher, A.A. Allergic contact dermatitis and conjunctivitis from benzalkonium chloride. Cutis 39:381-383, 1987.
21. Baudouin, C. Allergic reaction to topical eyedrops. Curr. Opin. Allergy Clin. Immunol. 5:459-463, 2005.
22. Becquet, F., Goldschild, M., Moldovan, M.S., et al. Histopathological effects of topical ophthalmic preservatives on rat corneoconjunctival surface. Curr. Eye Res. 17:419-425, 1998.
23. Ichijima, H., Petroll, W.M., Jester, J.V., et al. Confocal microscopic studies of living rabbit cornea treated with benzalkonium chloride. Cornea 11:221-225, 1992.
24. McCarey, B.E., and Reaves, T.A. Effect of tear lubricating solutions on in vivo corneal epithelial permeability. Curr. Eye Res. 16:44-50, 1997.